CA's Stem-Cell Agency Still Considers Issuing $400M in Debt Despite Deal to Balance Budget

Earlier this month the California Institute for Regenerative Medicine said it plans to privately sell $200 million in bonds in this and the following fiscal year in case it will be unable to access public capital.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.